ICU Medical Q2 Adjusted EPS of $2.37 Beats Sharply, FY2026 Outlook Raised

SentiSense · Published · Updated

ICU Medical reported a 46 cent beat in Q2 EPS and exceeded quarterly revenue estimates. The company offered revised guidance following strong quarterl...

Sign in to read the full story. Free accounts include 20 full reads a month.

Sign in or create a free account

Powered by SentiSense - Intelligent Market Analysis